Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction

The use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (<b>6a</b&g...

Full description

Bibliographic Details
Main Authors: Haoran Wang, Jianhua Wei, Hong Jiang, Ye Zhang, Caina Jiang, Xianli Ma
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/5/1453
id doaj-7529e8954a1b49e580b40705eeef27a7
record_format Article
spelling doaj-7529e8954a1b49e580b40705eeef27a72021-03-08T00:02:52ZengMDPI AGMolecules1420-30492021-03-01261453145310.3390/molecules26051453Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis InductionHaoran Wang0Jianhua Wei1Hong Jiang2Ye Zhang3Caina Jiang4Xianli Ma5School of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaSchool of Pharmacy, Guilin Medical University, Guilin 541199, ChinaThe use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (<b>6a</b>–<b>6c</b>) were synthesized as antitumor agents. Compounds <b>6a</b> and <b>6c</b> exhibited better in vitro antiproliferative activity against seven tumor cell lines than cisplatin, they displayed no evident resistance in the cisplatin-resistant cell line A549/DPP. Importantly, <b>6a </b>effectively inhibited tumor growth in the T-24 xenograft mouse model in comparison with cisplatin. Gel electrophoresis assay indicated that DNA was the potential targets of <b>6a</b> and <b>6c</b>, and the upregulation of p-H2AX confirmed this result. Cell cycle arrest studies demonstrated that <b>6a</b> and <b>6c</b> arrested the cell cycle at G1 phase, accompanied by the upregulation of the expression levels of the antioncogene p27 and the down-regulation of the expression levels of cyclin E. In addition, <b>6a</b> and<b> 6c</b> caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-9, cytochrome c, intracellular Ca<sup>2+</sup> release, reactive oxygen species (ROS) generation and the downregulation of Bcl-2. These mechanistic study results suggested that <b>6a</b> and <b>6c</b> exerted their antitumor activity by inducing DNA damage, and consequently causing G1 stage arrest and the induction of apoptosis.https://www.mdpi.com/1420-3049/26/5/1453dithiocarbamateruthenium polypyridyl complexesantitumor activityDNA damagecell cycle arrestapoptosis
collection DOAJ
language English
format Article
sources DOAJ
author Haoran Wang
Jianhua Wei
Hong Jiang
Ye Zhang
Caina Jiang
Xianli Ma
spellingShingle Haoran Wang
Jianhua Wei
Hong Jiang
Ye Zhang
Caina Jiang
Xianli Ma
Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
Molecules
dithiocarbamate
ruthenium polypyridyl complexes
antitumor activity
DNA damage
cell cycle arrest
apoptosis
author_facet Haoran Wang
Jianhua Wei
Hong Jiang
Ye Zhang
Caina Jiang
Xianli Ma
author_sort Haoran Wang
title Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
title_short Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
title_full Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
title_fullStr Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
title_full_unstemmed Design, Synthesis and Pharmacological Evaluation of Three Novel Dehydroabietyl Piperazine Dithiocarbamate Ruthenium (II) Polypyridyl Complexes as Potential Antitumor Agents: DNA Damage, Cell Cycle Arrest and Apoptosis Induction
title_sort design, synthesis and pharmacological evaluation of three novel dehydroabietyl piperazine dithiocarbamate ruthenium (ii) polypyridyl complexes as potential antitumor agents: dna damage, cell cycle arrest and apoptosis induction
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2021-03-01
description The use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (<b>6a</b>–<b>6c</b>) were synthesized as antitumor agents. Compounds <b>6a</b> and <b>6c</b> exhibited better in vitro antiproliferative activity against seven tumor cell lines than cisplatin, they displayed no evident resistance in the cisplatin-resistant cell line A549/DPP. Importantly, <b>6a </b>effectively inhibited tumor growth in the T-24 xenograft mouse model in comparison with cisplatin. Gel electrophoresis assay indicated that DNA was the potential targets of <b>6a</b> and <b>6c</b>, and the upregulation of p-H2AX confirmed this result. Cell cycle arrest studies demonstrated that <b>6a</b> and <b>6c</b> arrested the cell cycle at G1 phase, accompanied by the upregulation of the expression levels of the antioncogene p27 and the down-regulation of the expression levels of cyclin E. In addition, <b>6a</b> and<b> 6c</b> caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-9, cytochrome c, intracellular Ca<sup>2+</sup> release, reactive oxygen species (ROS) generation and the downregulation of Bcl-2. These mechanistic study results suggested that <b>6a</b> and <b>6c</b> exerted their antitumor activity by inducing DNA damage, and consequently causing G1 stage arrest and the induction of apoptosis.
topic dithiocarbamate
ruthenium polypyridyl complexes
antitumor activity
DNA damage
cell cycle arrest
apoptosis
url https://www.mdpi.com/1420-3049/26/5/1453
work_keys_str_mv AT haoranwang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction
AT jianhuawei designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction
AT hongjiang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction
AT yezhang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction
AT cainajiang designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction
AT xianlima designsynthesisandpharmacologicalevaluationofthreenoveldehydroabietylpiperazinedithiocarbamaterutheniumiipolypyridylcomplexesaspotentialantitumoragentsdnadamagecellcyclearrestandapoptosisinduction
_version_ 1724229197635780608